« Back
Society of Immunotherapy of Cancer (SITC)
Nov 05 - Nov 09, 2025
The Immatics team is attending and will present three posters at the 40th Anniversary Annual Meeting of the Society for Immunotherapy of Cancer.
For more information, visit the conference website by clicking here.
SITC Poster Presentations
Date: November 7, 2025
Abstract: 579
Title: Quality of starting material result in high manufacturability and favorable product phenotype of IMA203, a PRAME-directed TCR T-cell therapy
Presenter: Alper Kursunel – Immatics Biotechnologies Gmbh
Date: November 7, 2025
Abstract: 603
Title: SUPRAME: A Phase 3 trial evaluating IMA203 PRAME-directed TCR T-cell therapy vs investigator’s choice in previously treated advanced cutaneous melanoma
Presenter: Justin Moser – HonorHealth Research Institute
Date: November 8, 2025
Abstract: 590
Title: A first-in-human, phase 1 trial of IMA203 PRAME-directed TCR T-cell therapy with PRAME-encoding mRNA-4203 in previously treated, unresectable or metastatic cutaneous melanoma or synovial sarcoma
Presenter: James Smithy – Memorial Sloan Kettering Cancer Center
Location